Dr Reddys Laboratories LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Dr. Reddy's Laboratories, Reports 4.1% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.1% beneficial ownership stake in Dr. Reddy's Laboratories Ltd. as of March 31, 2025.